Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and teenagers aged 18 or younger
- People who have been diagnosed with mild to moderate ulcerative colitis, based on a standard activity score (called PUCAI) and results from a colonoscopy
- People who have been recently diagnosed with ulcerative colitis and have not yet received treatment, as well as those who have had the condition for a longer period of time
Who may not be able to join:
- People who have a severe, acute (sudden and serious) form of ulcerative colitis
- People who currently have a gastrointestinal infection, such as C. difficile or cytomegalovirus
- People who have been diagnosed with Crohn's disease
- People who have been diagnosed with indeterminate colitis or a condition called IBD-U (where the type of inflammatory bowel disease is unclear)
- People who have used steroids or antibiotics in the past three months — though people on biologic medications (a type of specialist treatment) may be considered if their dose has been stable for at least three months; the treating doctor makes the final decision on eligibility
- People who have other long-term inflammatory or autoimmune conditions, or who have previously had cancer
- Women who are pregnant, or women of childbearing age who are not using contraception at the time of joining
- People who have existing kidney or liver problems
- People whose platelet count (a measure in a blood test) is below 50,000, as this means a colonoscopy cannot be safely performed, which is required for the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kevin Mollen, University of Pittsburgh
Phone: 412-692-6272
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients screened; Proportion of patients screened who meet inclusion/exclusion criteria; Enrollment percentage; Completion percentage; Reasons for exclusion; Dropout rate; Reasons for dropout
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.